IL-24 is a cytokine and potential powerful therapeutic agent for anti-cancer.[29,32] Previous work of our group has defined that the cytokine, IL-24, had powerful anti-tumor activity, in vitro or in vivo.[23] Here, we explored whether IL-24 is a potential therapeutic gene for the treatment of APL. Here, IL24 is linked to acute promyelocytic leukemia.